Evidence map›Paper›PMID 31533694›Full record

ArticleBMC surgery2019

Early outcome of Frey's procedure for chronic pancreatitis: Nepalese tertiary center experience.

Dhruba Narayan Sah, Ramesh Singh Bhandari, Yogendra Prasad Singh, Pradeep Vaidya, Prasan B S Kansakar, Bikal Ghimire, Bishnu Kandel, Jayant Kumar Sah, Paleswan Joshi Lakhey

Open access · goldAbstract read
In one paragraph

Article in BMC surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Dhruba Narayan SahDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal. drshah_dn@live.com.ORCID http://orcid.org/0000-0001-6385-4466
Ramesh Singh BhandariDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Yogendra Prasad SinghDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Pradeep VaidyaDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Prasan B S KansakarDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Bikal GhimireDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Bishnu KandelDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Jayant Kumar SahDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Paleswan Joshi LakheyDepartment of GI & General Surgery, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, P. O - 1524, Kathmandu, 00977, Nepal.
Tribhuvan University Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic pancreatitis is a progressive and persistent inflammatory disease resulting in pancreatic insufficiency leading to diabetes and steatorrhea. Abdominal pain is the most debilitating feature and is often refractory to treatment. Medical management with adequate analgesia and replacement of pancreatic enzyme supplements is the first line in management of chronic pancreatitis. Surgery is reserved for those who fail medical management. The choice of surgical procedure and timing of surgery is a topic of debate. The objective of this study was to analyze surgical safety along with short- and long- term outcomes of Frey's procedure for patients suffering from chronic pancreatitis.

methodsThis was a retrospective review of cases of chronic pancreatitis who underwent Frey's procedure from 2016 January to 2019 February at Tribhuvan University Teaching Hospital. Demographics, intraoperative findings, perioperative outcomes, and short- and long-time outcomes were analyzed.

resultsTotal of 26 patients (age ranged 17-52, male - 14) underwent Frey's procedure in the study period. Alcohol was etiology in six patients while the majority (76.9%) were nonalcoholic. Half of the patients had tropical pancreatitis. Intractable pain was present in all cases along with pseudocyst in three and pseudoaneurysm in one case. The mean preoperative Izbicki scores were 53.4 ± 17.6. Six patients had diabetes and two patients had steatorrhea. Major complications were seen in 11.5% of cases while mortality was in one patient. The median duration of the hospital stay was seven days. Over a median follow up of 17 months (range, 3-38), there were significantly lower pain scores postoperatively and 92% were pain-free. Only one new case of diabetes developed postoperatively.

conclusionOur early experiences suggests that Frey's procedure can be a safe option for patients with chronic pancreatitis, with acceptable perioperative morbidity with adequate pain relief without worsening of pancreatic endocrine and exocrine function.

Indexed as

AdolescentAdultFemaleHumansMaleMiddle AgedNepalPancreatectomyPancreaticojejunostomyPancreatitis, ChronicRetrospective StudiesTertiary Care CentersTreatment OutcomeYoung AdultChronic pancreatitisFrey’s procedureIzbickiNepalSurgery

Identifiers

PMID31533694
PMCPMC6751617
OpenAlexW2974891549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.